Helicobacter Pylori Infection in Acute Myocardial Infarction Patients
Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05788055
Collaborator
(none)
200
9
Study Details
Study Description
Brief Summary
This study aims to investigate the association between H.Pylori and ACS .
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The study is based on show the relationship between H.Pylori infection and Acute Coronary Syndrome .
Active H.Pylori infection is common in ACS and may represent a modifiable risk factor for upper gastrointestinal bleeding.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Study of Helicobacter Pylori Infection in Acute Myocardial Infarction Patients
Anticipated Study Start Date
:
Apr 1, 2023
Anticipated Primary Completion Date
:
Oct 1, 2023
Anticipated Study Completion Date
:
Jan 1, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Acute Coronary Syndrome Patients Stool Analysis will be done for all cases to detect H.pylori Antigen and results will be analysed into infected patients and non infected patients. |
Diagnostic Test: Stool Analysis
Stool Analysis to detect H.Pylori Antigen in Stool
|
| Chronic Stable Angina Patients Stool Analysis will be done for all cases to detect H.pylori Antigen and results will be analysed into infected patients and non infected patients. |
Diagnostic Test: Stool Analysis
Stool Analysis to detect H.Pylori Antigen in Stool
|
Outcome Measures
Primary Outcome Measures
- Comparison of results of H.Pylori antigen with ACS [from the day of admission to the day of disharge of sohag university hospitals]
Analysis of H.Pylori antigen and compare with ECG findings and cardiac enzymes
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- All patients presenting by acute coronary syndrome to Coronary Care Units, Internal Medicine Department, Sohag Faculty of Medicine from 18 .
Exclusion Criteria:
- 1.Patients with Cardiogenic Shock. 2. Renal Impairment.(Creatinine Clearence <60) 3. A known systemic inflammatory condition. 4.They had taken any antibiotics in the previous 1 months. 5.They had taken any proton pump inhibitors in previous 2 weeks. 6.Gastrointestinal Bleeding.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Sohag University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
Asmaa Ezz Mostafa,
Dr,
Sohag University
ClinicalTrials.gov Identifier:
NCT05788055
Other Study ID Numbers:
- H.Pylori and AMI
First Posted:
Mar 28, 2023
Last Update Posted:
Mar 28, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: